ReviewCurrent opinion in infectious diseases2026
Unresolved questions in pediatric dengue: from disease mechanisms to prevention.
Review in Current opinion in infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewDespite recent advances in understanding dengue infection, substantial gaps remain in its epidemiology, pathogenesis, diagnosis, and prevention, including vaccine development and its long-term impact. This review summarizes recent findings and highlights the most pressing research needs to advance the field and reduce individual and public health burden. RECENT
findingsDengue burden has increased, particularly among children and adolescents, and it has expanded into previously unaffected regions. Still, current data likely underestimates the true burden due to suboptimal surveillance systems. Improving control will require a better understanding of severe dengue pathogenesis, where key gaps remain, alongside reassessment of diagnostic limitations in the context of increasing vaccine availability. Vaccines represent an important complementary tool, with several candidates under study and two currently in use, each with distinct strengths, limitations, and unresolved questions. SUMMARY: More extensive research and investment are needed to address the growing burden of dengue, including severe outbreaks and geographic spread. Meanwhile, stronger regulatory engagement in the development and evaluation of innovative therapeutic and preventive measures is essential, particularly in low-income and middle-income regions that bear the highest burden. Clear communication and education on dengue, its impact, and available preventive measures proven to be well tolerated and effective are also critical to strengthen trust, improve uptake, and maximize public health impact.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.